Inventor
OAKES BENJAMIN
US14 patents
⚠️ This page may combine multiple inventors who share the name “OAKES BENJAMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCRIBE THERAPEUTICS INC
11 patentsUS11560555B2Jan 24, 2023
Engineered proteins
SCRIBE THERAPEUTICS INC15 citations91
US12084692B2Sep 10, 2024
Guide scaffolds
SCRIBE THERAPEUTICS INC5 citations82
US11535835B1Dec 27, 2022
Compositions and methods for the targeting of rhodopsin
SCRIBE THERAPEUTICS INC7 citations82
US11613742B2Mar 28, 2023
Compositions and methods for the targeting of SOD1
SCRIBE THERAPEUTICS INC4 citations71
US12163125B2Dec 10, 2024
Engineered class 2 type V CRISPR systems
SCRIBE THERAPEUTICS INC5 citations70
US11976277B2May 7, 2024
Particle delivery systems
SCRIBE THERAPEUTICS INC3 citations69
US12551560B2Feb 17, 2026
Compositions and methods for use in immunotherapy
SCRIBE THERAPEUTICS INC0 citations59
US12559743B2Feb 24, 2026
Engineered guide scaffolds
SCRIBE THERAPEUTICS INC0 citations58
US12553037B2Feb 17, 2026
Engineered class 2, type V repressor systems
SCRIBE THERAPEUTICS INC0 citations56
US12594349B2Apr 7, 2026
Compositions and methods for the targeting of PCSK9
SCRIBE THERAPEUTICS INC0 citations55
US12551573B2Feb 17, 2026
Compositions and methods for the targeting of PCSK9
SCRIBE THERAPEUTICS INC0 citations55
UNIV CALIFORNIA
3 patentsUS10494620B2Dec 3, 2019
Methods and compositions for modifying a single stranded target nucleic acid
UNIV CALIFORNIA3 citations69
US11008555B2May 18, 2021
Variant Cas9 polypeptides comprising internal insertions
UNIV CALIFORNIA1 citations57
US9994831B2Jun 12, 2018
Methods and compositions for modifying a single stranded target nucleic acid
UNIV CALIFORNIA1 citations48